American Gene Technologies International Inc.

États‑Unis d’Amérique


 
Quantité totale PI 88
Rang # Quantité totale PI 14 977
Note d'activité PI 2,6/5.0    53
Rang # Activité PI 13 731
Classe Nice dominante Éducation, divertissements, acti...

Brevets

Marques

51 4
10 1
21 1
0
 
Dernier brevet 2024 - On demand expression of exogenou...
Premier brevet 2009 - Safe lentiviral vectors for targ...
Dernière marque 2023 - ADDIMMUNE
Première marque 2021 - AGT

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Pre-immunization and immunotherapy. The present invention relates generally to immunization and ...
2023 Invention Hiv pre-immunization and immunotherapy. The present invention relates generally to immunization ...
Invention Compositions and methods for treating phenylketonuria. A lentiviral vector system for expressing...
Invention On demand expression of exogenous factors in lymphocytes. The present disclosure relates general...
Invention Methods of manufacturing genetically-modified lymphocytes. The present disclosure relates genera...
P/S Pharmaceuticals, medicinal and biological preparations for the treatment of HIV; pharmaceuticals ...
P/S Pharmaceuticals, medicinal and biological preparations for the treatment of HIV; pharmaceuticals...
Invention Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules. The present app...
P/S pharmaceuticals, medicinal and biological preparations for the treatment of HIV providing online ...
Invention Viral vectors for treating parkinson's disease. A lentiviral vector system for expressing a lent...
2022 Invention Methods and compositions for the activation of gamma-delta t-cells. The present invention relate...
Invention Vector system for expressing regulatory rna. Viral vectors, lentiviral particles, and modified c...
Invention Engineered nk cells and methods of treating cancer. The present disclosure relates generally to ...
Invention Engineered nk cells and methods of treating cancer. The present disclosure relates generally to m...
Invention Combination vectors and methods for treating cancer. A composition for treating cancer is disclo...
2021 P/S Pharmaceuticals, medicinal and biological preparations for modulation of patient gene expression ...
P/S Providing online newsletters in the fields of pharmaceuticals, medicines, treatments of diseases ...
Invention Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules. The present appl...
Invention Combination vectors and methods for treating cancer. A composition for treating cancer is disclos...
Invention On demand expression of exogenous factors in lymphocytes to treat hiv. The present disclosure re...
Invention On demand expression of exogenous factors in lymphocytes to treat hiv. The present disclosure rel...
Invention Hiv pre-immunization and immunotherapy. The present invention relates generally to immunization a...
2020 Invention Methods of producing cells resistant to hiv infection. The present invention relates generally to...
Invention Methods and compositions for the activation of gamma-delta t-cells. The present invention relates...
Invention Optimized phenylananine hydroxylase expression. A lentiviral vector system for expressing a lent...
Invention Optimized phenylalanine hydroxylase expression. A lentiviral vector system for expressing a lenti...
2019 Invention Vector system for expressing regulatory rna. Viral vectors, lentiviral particles, and modified ce...
Invention Methods of manufacturing genetically-modified lymphocytes. The present disclosure relates general...
2018 Invention Vectors with promoter and enhancer combinations for treating phenylketonuria. A lentiviral vecto...
Invention Vectors with promoter and enhancer combinations for treating phenylketonuria. A lentiviral vector...
Invention Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells. ...
Invention Compositions and methods for treating phenylketonuria. A lentiviral vector system for expressing ...
Invention Hiv immunotherapy with no pre-immunization step. The present invention relates generally to immu...
2017 Invention Viral vectors for treating parkinson's disease. A lentiviral vector system for expressing a lenti...
Invention Non-integrating viral delivery system and methods related thereto. A non-integrating viral deliv...
2016 Invention Non-integrating viral delivery system and methods related thereto. A non-integrating viral delive...